Isitri (Isosorbide Dinitrate)

Isitri (isosorbide dinitrate) is used in the nitrate class to manage several cardiovascular conditions.

• Angina pectoris: provides rapid relief of chest pain by decreasing myocardial oxygen demand through vasodilation.
• Acute coronary syndrome: stabilizes coronary blood flow and limits ischemic injury during acute events.
• Heart failure: reduces preload and afterload, improving cardiac output and symptom burden in chronic heart failure.

• Isosorbide dinitrate is a prodrug that releases nitric oxide in vascular smooth muscle. The nitric oxide activates guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of arterial and venous smooth muscle. This vasodilatory effect lowers both preload and afterload, decreasing myocardial oxygen consumption and improving coronary blood flow. The resultant hemodynamic changes also help to alleviate myocardial ischemia and improve exercise tolerance.

Isosorbide dinitrate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: throbbing pain often triggered by vasodilation, may worsen with activity.
• Hypotension: noticeable drop in blood pressure causing light‑headedness, especially when standing.
• Flushing: warm, reddening skin especially on the face and neck, transient.
• Dizziness: sensation of unsteadiness that may accompany blood pressure changes, usually resolves with rest.

Serious or Rare Side Effects

• Severe hypotension: profound blood pressure fall that can lead to shock and organ hypoperfusion.
• Syncope: sudden fainting episodes due to inadequate cerebral perfusion, may result in injury.
• Allergic reactions: rash, bronchospasm, or anaphylaxis requiring immediate medical attention and discontinuation.

When using Isitri, clinicians should observe several precautions to minimize risks and ensure therapeutic effectiveness.

• Monitor blood pressure: check systolic and diastolic values before and during therapy.
• Avoid concurrent nitrates: combined use can cause excessive vasodilation and severe hypotension.
• Contraindicated with phosphodiesterase‑5 inhibitors: risk of life‑threatening blood pressure drop.
• Adjust dose in renal or hepatic impairment: reduced clearance may increase drug exposure.
• Educate patients on orthostatic changes: advise slow position changes to prevent dizziness.
• Store at room temperature: keep in original container, protect from moisture and light.

Isitri can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Sildenafil, tadalafil, and other PDE5 inhibitors: concurrent use may cause severe, potentially life‑threatening hypotension.
• Other nitrates (e.g., nitroglycerin, isosorbide mononitrate): additive vasodilatory effect can lead to dangerous blood pressure fall.
• Sodium nitroprusside: combined vasodilation may precipitate profound hypotension and reflex tachycardia.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask typical tachycardic response to hypotension, requiring careful heart‑rate monitoring.
• Diuretics: can enhance the hypotensive response, so dose adjustments and close observation are advised.
• Alcohol: may increase dizziness and blood‑pressure lowering effects; patients should limit intake.